162 related articles for article (PubMed ID: 33612076)
1. Identification of the binding interactions of some novel antiviral compounds against Nsp1 protein from SARS-CoV-2 (COVID-19) through high throughput screening.
Chowdhury N; Bagchi A
J Biomol Struct Dyn; 2022 Sep; 40(14):6634-6641. PubMed ID: 33612076
[TBL] [Abstract][Full Text] [Related]
2.
Kumar R; Kumar R; Tanwar P
J Biomol Struct Dyn; 2022 Oct; 40(16):7394-7407. PubMed ID: 33715592
[TBL] [Abstract][Full Text] [Related]
3. Two Ligand-Binding Sites on SARS-CoV-2 Non-Structural Protein 1 Revealed by Fragment-Based X-ray Screening.
Ma S; Damfo S; Lou J; Pinotsis N; Bowler MW; Haider S; Kozielski F
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293303
[TBL] [Abstract][Full Text] [Related]
4. Identification of potential drugs against SARS-CoV-2 non-structural protein 1 (nsp1).
de Lima Menezes G; da Silva RA
J Biomol Struct Dyn; 2021 Sep; 39(15):5657-5667. PubMed ID: 32657643
[TBL] [Abstract][Full Text] [Related]
5. Drug targeting Nsp1-ribosomal complex shows antiviral activity against SARS-CoV-2.
Afsar M; Narayan R; Akhtar MN; Das D; Rahil H; Nagaraj SK; Eswarappa SM; Tripathi S; Hussain T
Elife; 2022 Mar; 11():. PubMed ID: 35323109
[TBL] [Abstract][Full Text] [Related]
6. Multi-targeting approach for nsp3, nsp9, nsp12 and nsp15 proteins of SARS-CoV-2 by Diosmin as illustrated by molecular docking and molecular dynamics simulation methodologies.
Kumar S; Sharma PP; Upadhyay C; Kempaiah P; Rathi B; Poonam
Methods; 2021 Nov; 195():44-56. PubMed ID: 33639316
[TBL] [Abstract][Full Text] [Related]
7. Structure-based virtual screening, in silico docking, ADME properties prediction and molecular dynamics studies for the identification of potential inhibitors against SARS-CoV-2 M
Mohan A; Rendine N; Mohammed MKS; Jeeva A; Ji HF; Talluri VR
Mol Divers; 2022 Jun; 26(3):1645-1661. PubMed ID: 34480682
[TBL] [Abstract][Full Text] [Related]
8. Prediction of potential inhibitors against SARS-CoV-2 endoribonuclease: RNA immunity sensing.
Al-Rashedi NAM; Munahi MG; Ah ALObaidi L
J Biomol Struct Dyn; 2022 Jul; 40(11):4879-4892. PubMed ID: 33357040
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the effects of chlorhexidine and several flavonoids as antiviral purposes on SARS-CoV-2 main protease: molecular docking, molecular dynamics simulation studies.
Tatar G; Salmanli M; Dogru Y; Tuzuner T
J Biomol Struct Dyn; 2022 Oct; 40(17):7656-7665. PubMed ID: 33749547
[TBL] [Abstract][Full Text] [Related]
10. The antiviral activity of a small molecule drug targeting the NSP1-ribosome complex against Omicron, especially in elderly patients.
Shen M; Ding P; Luan G; Du T; Deng S
Front Cell Infect Microbiol; 2023; 13():1141274. PubMed ID: 36960047
[TBL] [Abstract][Full Text] [Related]
11. Structure of the SARS-CoV-2 Nsp1/5'-Untranslated Region Complex and Implications for Potential Therapeutic Targets, a Vaccine, and Virulence.
Vankadari N; Jeyasankar NN; Lopes WJ
J Phys Chem Lett; 2020 Nov; 11(22):9659-9668. PubMed ID: 33135884
[TBL] [Abstract][Full Text] [Related]
12. Virtual screening of phytochemicals by targeting multiple proteins of severe acute respiratory syndrome coronavirus 2: Molecular docking and molecular dynamics simulation studies.
Azeem M; Mustafa G; Mahrosh HS
Int J Immunopathol Pharmacol; 2022; 36():3946320221142793. PubMed ID: 36442514
[TBL] [Abstract][Full Text] [Related]
13.
Kumar B; Parasuraman P; Murthy TPK; Murahari M; Chandramohan V
J Biomol Struct Dyn; 2022 Oct; 40(17):7796-7814. PubMed ID: 33759690
[TBL] [Abstract][Full Text] [Related]
14. Finding potent inhibitors against SARS-CoV-2 main protease through virtual screening, ADMET, and molecular dynamics simulation studies.
Roy R; Sk MF; Jonniya NA; Poddar S; Kar P
J Biomol Struct Dyn; 2022 Sep; 40(14):6556-6568. PubMed ID: 33682642
[TBL] [Abstract][Full Text] [Related]
15. Identification of naphthyridine and quinoline derivatives as potential Nsp16-Nsp10 inhibitors: a pharmacoinformatics study.
Aldahham BJM; Al-Khafaji K; Saleh MY; Abdelhakem AM; Alanazi AM; Islam MA
J Biomol Struct Dyn; 2022 Jun; 40(9):3899-3906. PubMed ID: 33252031
[TBL] [Abstract][Full Text] [Related]
16. Modelling studies reveal the importance of the C-terminal inter motif loop of NSP1 as a promising target site for drug discovery and screening of potential phytochemicals to combat SARS-CoV-2.
Prabhu D; Rajamanikandan S; Sureshan M; Jeyakanthan J; Saraboji K
J Mol Graph Model; 2021 Jul; 106():107920. PubMed ID: 33933885
[TBL] [Abstract][Full Text] [Related]
17. Systematic virtual screening in search of SARS CoV-2 inhibitors against spike glycoprotein: pharmacophore screening, molecular docking, ADMET analysis and MD simulations.
Dhameliya TM; Nagar PR; Gajjar ND
Mol Divers; 2022 Oct; 26(5):2775-2792. PubMed ID: 35132518
[TBL] [Abstract][Full Text] [Related]
18. Plant-Derived Antiviral Compounds as Potential Entry Inhibitors against Spike Protein of SARS-CoV-2 Wild-Type and Delta Variant: An Integrative in SilicoApproach.
Ambrose JM; Kullappan M; Patil S; Alzahrani KJ; Banjer HJ; Qashqari FSI; Raj AT; Bhandi S; Veeraraghavan VP; Jayaraman S; Sekar D; Agarwal A; Swapnavahini K; Krishna Mohan S
Molecules; 2022 Mar; 27(6):. PubMed ID: 35335139
[TBL] [Abstract][Full Text] [Related]
19. Structure-based virtual screening and molecular dynamics simulation of SARS-CoV-2 Guanine-N7 methyltransferase (nsp14) for identifying antiviral inhibitors against COVID-19.
Selvaraj C; Dinesh DC; Panwar U; Abhirami R; Boura E; Singh SK
J Biomol Struct Dyn; 2021 Aug; 39(13):4582-4593. PubMed ID: 32567979
[TBL] [Abstract][Full Text] [Related]
20. In silico prediction of potential inhibitors for the main protease of SARS-CoV-2 using molecular docking and dynamics simulation based drug-repurposing.
Kumar Y; Singh H; Patel CN
J Infect Public Health; 2020 Sep; 13(9):1210-1223. PubMed ID: 32561274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
